Yet the same day, CVS filed its annual report to shareholders with a new paragraph about “uncertainty” around changing health ...

For the second year running, nonprofit consulting firm Good Energy applied its Climate Reality Check to the actual ...

CVS Health (CVS) has made an impressive comeback in 2025, with its stock soaring 45% so far this year. This sharp rebound ...

Before serving as interim president at Caremark, DeVaney led sales and account management as president of employer and health ...

Health Execs Showered Trump With Millions. Healthcare executives paid millions to attend at least six dinners with President ...

Enterprise broke a 2-2 tie with two runs in the bottom of the fifth and two in the sixth to down Rehobeth 6-2 in high school ...

Ed DeVaney’s promotion is the latest leadership shakeup at CVS Health as the company works on a multi-year turnaround plan.

The high cost of sickle cell gene therapies is pushing private insurers and Medicaid programs to develop new payment models.

Earnings have fallen but are still strong enough to meet CVS Health's dividend commitment. Management expects adjusted earnings for 2025 to land in a range between $5.75 and $6 per share. That's ...

CVS Health has named Ed DeVaney as president of its pharmacy benefit manager, CVS Caremark. | DeVaney has served as interim ...

CVS Health® (NYSE: CVS) named Ed DeVaney president of the company's CVS Caremark pharmacy benefit management business. He was named interim president in December 2024. DeVaney will report to Prem Shah ...